Kura Oncology Inc (NASDAQ:KURA)
| 12.15 Delayed Data As of May 19 |  +0.23 / +1.93%Today’s Change | 10.41 Today|||52-Week Range 24.62 | -13.21% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 20.0K | 31.0K | 30.0K | 10.0K | ||
| Operating Expenses | Gross Income | -20.0K | -31.0K | -30.0K | -10.0K | |
| General Expenses | 23.6M | 28.3M | 36.0M | 62.9M | ||
| Research And Development | 17.5M | 20.4M | 26.4M | 46.8M | ||
| Total Operating Expenses | 23.6M | 28.4M | 36.1M | 62.9M | ||
| Non-Operating Expenses | Operating Income | -23.6M | -28.4M | -36.1M | -62.9M | |
| Extraordinary Charge | -268.0K | 0.00 | 0.00 | -498.0K | ||
| Interest Expense On Debt | 88.0K | 577.0K | 888.0K | 970.0K | ||
| Other Expenses | 1.2M | 885.0K | 780.0K | 735.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -22.6M | -27.6M | -35.4M | -60.4M | |
| Net Income | -22.6M | -27.6M | -35.4M | -60.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 9.9M | 18.7M | 23.2M | 35.2M | |
| Shares To Calculate EPS Diluted | 9.9M | 18.7M | 23.2M | 35.2M | ||
| Earnings Per Share | EPS | -$2.28 | -$1.47 | -$1.52 | -$1.72 | |
| EPS Diluted | -$2.28 | -$1.47 | -$1.52 | -$1.72 | ||
